National Comprehensive Cancer Network (NCCN) presents preliminary data from a study demonstrating the usability of the Health Equity Report Card (HERC) tool during the American Public Health Association (APHA) Annual Meeting and Expo.
Glucagon-like peptide-1-receptor agonists (GLP-1RA) are medications that are increasingly prescribed for patients with type 2 diabetes and congestive heart failure. Reports of GLP-1RA–associated acute kidney injury (AKI) have emerged, but the risk of GLP-1RA–associated AKI among patients on anti-cancer drugs is unclear. Surprisingly, new research suggests that taking GLP-1RA is not associated with an increased risk of AKI in patients receiving anti-cancer therapies. The findings will be presented at ASN Kidney Week 2024 October 23– 27.
Dr. David Braun, a medical oncologist at Yale Cancer Center, will be awarded the Christopher G. Wood Rising Star Award by the Kidney Cancer Association at November's International Kidney Cancer Symposium.
Cedars-Sinai experts in gastroenterology attending the Oct. 25-30 American College of Gastroenterology (ACG) Annual Scientific Meeting in Philadelphia are available for interviews about clinical and scientific developments in the field of digestive diseases.
A newly described stage of a lymph node-like structure seen in liver tumors after presurgical immunotherapy may be vital to successfully treating patients with hepatocellular carcinoma, according to a study by researchers from the Johns Hopkins Kimmel Cancer Center.
Researchers at The University of Texas at El Paso have created a portable device that can detect colorectal and prostate cancer more cheaply and quickly than prevailing methods. The team believes the device may be especially helpful in developing countries, which experience higher cancer mortality rates due in part to barriers to medical diagnosis.
Transforming breast cancer treatment and prevention, a breast-cancer survivor and doctoral candidate focuses her research on adolescent and young adult cancer disparities, research on tracking glioblastoma progression and more are included in this month's tip sheet.
Researchers from The University of Texas MD Anderson Cancer Center demonstrated that anti-PD-L1 immunotherapy in combination with mutation-directed targeted therapy extended overall survival (OS) in patients with anaplastic thyroid carcinoma (ATC).
The 2022 Panjiayuan Consensus Conference, held by the National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, has introduced pivotal advancements in prostate targeted biopsy (TB) strategies and development, marking a significant leap forward in the diagnosis and management of prostate cancer (PCa).
New study in JNCCN-Journal of the National Comprehensive Cancer Network that finds that people diagnosed with an aggressive breast cancer subtype (HR-negative, HER2-positive) are more likely to live longer in states that participate in Medicaid expansion under the Affordable Care Act (ACA).
Breast cancer takes a major toll on Caribbean women. They are often diagnosed at a younger age than women in the U.S., and have one of the highest mortality rates worldwide. A new study in JAMA Network Open suggests that these higher rates may be linked to shifting patterns in reproductive health.
Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication.
A researcher at The University of Kansas Cancer Center is leading a national clinical trial to test a combination vaccine to prevent colon cancer in people with Lynch syndrome.
Javier Garcia Bermudez, Ph.D., an Assistant Professor in Children’s Medical Center Research Institute at UT Southwestern (CRI), is one of 67 scientists awarded a 2024 National Institutes of Health High-Risk, High-Reward (HRHR) Research grant.
Dr. Olivier Loudig, a scientist at the Center for Discovery Innovation, talks about groundbreaking research in non-invasive cancer detection. As public awareness of airborne pathogens has increased due to the COVID-19 pandemic, Dr. Loudig explores the hidden health clues found in our breath.
Two UC San Francisco faculty members, Alicia Fernandez, MD, professor of medicine, and Nola M. Hylton, PhD, a professor of radiology and biomedical imaging, have been elected to the National Academy of Medicine (NAM) this year, one of the highest honors in the field of health and medicine.
CRI is proud to announce the appointment of Rachael Brown, Chief Development Officer, and Scott Glenn, Chief Operations Officer.
The UCLA Urology department has been awarded $6 million from the California Department of Health Care Services to continue providing vital care and critical services to underinsured and uninsured Californians diagnosed with prostate cancer.
Showing results
1–1 of 1
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
